Nonclinical Safety Testing with Virtual Control...

By João L. Carapinha

March 31, 2026

Virtual Control Groups are set to reduce animal use in medicines development. The European Medicines Agency (EMA) has released a draft Qualification Opinion endorsing the use of Virtual Control Groups to replace or reduce concurrent control groups...
Advancing Health Technology Assessment MENA: Insights and Implications for th...
Advancing Participatory Arts Health in Dutch Care Systems
Tarlatamab for Small Cell Lung Cancer Treatment
FDA Approves Once-Weekly Basal Insulin Awiqli® for Type 2 Diabetes Management
Inflation Reduction Act Impact on Clinical Trial Investment Trends
EU Alzheimer Approval Challenges: Anavex Withdraws Blarcamesine Application A...
South Africa Health Reform: Revitalizing the Crisis-Stricken Sector
NICE Pembrolizumab Recommendation for Locally Advanced Head and Neck Cancer T...
PEPFAR TB Impact: Averting Millions of Cases and Deaths Among HIV Patients
Vitamin B6 Depletion Risk in Carbidopa/Levodopa Therapy and Seizure Implications
Advancing Collaborative TB Innovation to Tackle Drug Resistance
Citation Analysis of Real-World Evidence in Medicare Drug Price Negotiations